Related Experiment Video
Updated: Oct 30, 2025

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
A cannabis oracle? Delphi method not a substitute for randomized controlled trials of cannabinoids as therapeutics
Kevin P Hill1,2, Donald I Abrams3
1Division of Addiction Psychiatry, Beth Israel Deaconess Medical Center, Grzymish 133, 330 Brookline Avenue, Boston, MA, 02215, USA. Khill1@bidmc.harvard.edu.
Background:
With millions of people using cannabinoids to treat a host of medical conditions, clinicians want guidance on how to utilize cannabinoids as pharmacotherapy in their practices. The Delphi method is a systematic, interactive forecasting method that aims to develop consensus best practices where guidelines are not available. BODY: A multidisciplinary group of global cannabinoid experts utilized a modified Delphi process to develop three protocols for the dosing and administration of cannabinoids to treat chronic pain. Two protocols recommend cannabidiol (CBD), for which there is limited evidence as an analgesic, starting well below doses required for other indications. Guidance on prescribing CBD for pain may demonstrate consensus recommendations based upon suboptimal evidence.
Conclusion:
Consensus processes like the Delphi method are well-meaning, but they are not a substitute for rigorous RCTs with large sample sizes, adequate duration, and standardized outcome measures.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Therapeutic Drug Monitoring: Drug Analysis Methods
Drug Therapy
Antianxiety Medications
Dosage Regimen: Individualization
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

